Halozyme Therapeutics HALO Operating margin

Operating margin at other companies

West Pharmaceutical ServicesWST

20.5%+0.8pp

AMP

Amphastar PharmaceuticalsAMPH

15.7%-9.5pp

AptarGroupATR

12.8%-1.2pp

Opko HealthOPK

-8.2%-3.5pp

Amneal Pharmaceuticals, Inc.AMRX

14.6%+1.4pp

Aquestive Therapeutics, Inc.AQST

-111.2%+96.3pp

FAQ

What is Halozyme Therapeutics's operating margin?

Halozyme Therapeutics (HALO) reported operating margin of 59.3% in Q3 2025.

How has Halozyme Therapeutics's operating margin changed year-over-year?

Halozyme Therapeutics's operating margin increased by 17.8% year-over-year, from 50.4% to 59.3%.

What is the long-term trend for Halozyme Therapeutics's operating margin?

Over 4 years (2020 to 2024), Halozyme Therapeutics's operating margin has grown at a 0.2% compound annual growth rate (CAGR), from 53.9% to 54.3%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.